rs398123102

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong

The NM_000033.4(ABCD1):​c.1553G>A​(p.Arg518Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000912 in 1,096,719 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R518W) has been classified as Likely pathogenic.

Frequency

Genomes: not found (cov: 24)
Exomes 𝑓: 9.1e-7 ( 0 hom. 0 hem. )

Consequence

ABCD1
NM_000033.4 missense

Scores

12
4
1

Clinical Significance

Pathogenic criteria provided, multiple submitters, no conflicts P:13

Conservation

PhyloP100: 10.0

Publications

11 publications found
Variant links:
Genes affected
ABCD1 (HGNC:61): (ATP binding cassette subfamily D member 1) The protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ALD subfamily, which is involved in peroxisomal import of fatty acids and/or fatty acyl-CoAs in the organelle. All known peroxisomal ABC transporters are half transporters which require a partner half transporter molecule to form a functional homodimeric or heterodimeric transporter. This peroxisomal membrane protein is likely involved in the peroxisomal transport or catabolism of very long chain fatty acids. Defects in this gene have been identified as the underlying cause of adrenoleukodystrophy, an X-chromosome recessively inherited demyelinating disorder of the nervous system. [provided by RefSeq, Jul 2008]
PLXNB3-AS1 (HGNC:40454): (PLXNB3 antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PM1
In a hotspot region, there are 8 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 5 uncertain in NM_000033.4
PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chrX-153740155-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 11307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.994
PP5
Variant X-153740156-G-A is Pathogenic according to our data. Variant chrX-153740156-G-A is described in ClinVar as [Pathogenic]. Clinvar id is 92317.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCD1NM_000033.4 linkc.1553G>A p.Arg518Gln missense_variant Exon 6 of 10 ENST00000218104.6 NP_000024.2 P33897

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCD1ENST00000218104.6 linkc.1553G>A p.Arg518Gln missense_variant Exon 6 of 10 1 NM_000033.4 ENSP00000218104.3 P33897
ABCD1ENST00000443684.2 linkn.556G>A non_coding_transcript_exon_variant Exon 5 of 6 3
PLXNB3-AS1ENST00000434284.1 linkn.72-1578C>T intron_variant Intron 1 of 2 3

Frequencies

GnomAD3 genomes
Cov.:
24
GnomAD2 exomes
AF:
0.00000548
AC:
1
AN:
182400
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
9.12e-7
AC:
1
AN:
1096719
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
362213
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26384
American (AMR)
AF:
0.00
AC:
0
AN:
35141
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19339
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30160
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54027
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40421
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4129
European-Non Finnish (NFE)
AF:
0.00000119
AC:
1
AN:
841110
Other (OTH)
AF:
0.00
AC:
0
AN:
46008
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
24
Alfa
AF:
0.00
Hom.:
0
ExAC
AF:
0.00000824
AC:
1
EpiCase
AF:
0.00
EpiControl
AF:
0.0000594

ClinVar

Significance: Pathogenic
Submissions summary: Pathogenic:13
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Adrenoleukodystrophy Pathogenic:7
Sep 23, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 518 of the ABCD1 protein (p.Arg518Gln). This variant is present in population databases (rs398123102, gnomAD 0.001%). This missense change has been observed in individual(s) with ABCD1-related conditions (PMID: 10190819, 12175782, 15811009, 16087056, 21068741, 21700483, 22479560, 23419472, 23566833, 26260157). In at least one individual the variant was observed to be de novo. This variant is also known as c.1939G>A. ClinVar contains an entry for this variant (Variation ID: 92317). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCD1 protein function with a positive predictive value of 95%. This variant disrupts the p.Arg518 amino acid residue in ABCD1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 14767898, 16415970). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -

Nov 07, 2021
Genome-Nilou Lab
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Apr 26, 2017
Molecular Diagnostics Laboratory, M Health Fairview: University of Minnesota
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 12, 2023
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Juno Genomics, Hangzhou Juno Genomics, Inc
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

PM2_Supporting+PS4+PM6+PP4+PM5 -

Apr 16, 2020
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant summary: ABCD1 c.1553G>A (p.Arg518Gln) results in a conservative amino acid change located in the AAA+ ATPase domain (IPR003593) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 5.5e-06 in 182500 control chromosomes (gnomAD). The variant c.1553G>A (also known as 1939G>A) has been reported in the literature in numerous individuals affected with Adrenoleukodystrophy (e.g. Imamura_1997, Takano_1999, Dvorakova_2001, Guimaraes_2002, Pan_2005, Coll_2005, Wiens_2019), and in several cases the lack of ALD protein in patient derived fibroblasts was demonstrated (e.g. Imamura_1997, Guimaraes_2002, Coll_2005). These data indicate that the variant is very likely to be associated with disease. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014, and both of them classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -

May 24, 2022
Baylor Genetics
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Pathogenic:5
Oct 23, 2020
Institute of Medical Genetics and Applied Genomics, University Hospital Tübingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 20, 2022
Revvity Omics, Revvity
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 08, 2012
Eurofins Ntd Llc (ga)
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 22, 2024
GeneDx
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 16996397, 25920484, 12175782, 23566833, 33920672, 30968598, 34826210, 21068741, 16415970, 20661612, 16087056, 27766264, 26260157, 11438993, 15811009, 23346902, 10190819, 27991992, 31074578, 32798492, 23419472, 24719486, 22479560, 15642351) -

Nov 01, 2022
CeGaT Center for Human Genetics Tuebingen
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

ABCD1: PM1, PM2, PS4:Moderate, PM5:Supporting, PP3, PP4, PS3:Supporting -

ABCD1-related disorder Pathogenic:1
May 29, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The ABCD1 c.1553G>A variant is predicted to result in the amino acid substitution p.Arg518Gln. This variant has been reported in multiple individuals with X-linked adrenoleukodystrophy (see for example, Table 3, Ping et al. 2006. PubMed ID: 16415970; Table 1, Coll et al. 2005. PubMed ID: 15811009; Table 2, Matsukawa et al. 2011. PubMed ID: 20661612). This variant is reported in 0.0012% of alleles in individuals of European (non-Finnish) descent in gnomAD. Alternate missense variants affecting the same amino acid (p.Arg518Trp and p.Arg518Gly) have been reported to be causative for X-linked adrenoleukodystrophy (Table 3, Ping et al. 2006. PubMed ID: 16415970; Table 2, Matsukawa et al. 2011. PubMed ID: 20661612). This variant is interpreted as pathogenic. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.68
D
BayesDel_noAF
Pathogenic
0.74
CADD
Pathogenic
30
DANN
Pathogenic
1.0
DEOGEN2
Pathogenic
0.96
D
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Pathogenic
0.87
D
MetaRNN
Pathogenic
0.99
D
MetaSVM
Pathogenic
0.93
D
MutationAssessor
Uncertain
2.2
M
PhyloP100
10
PrimateAI
Uncertain
0.60
T
PROVEAN
Uncertain
-3.6
D
REVEL
Pathogenic
0.94
Sift
Uncertain
0.0010
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.81
MutPred
0.97
Gain of methylation at K513 (P = 0.0396);
MVP
1.0
MPC
1.6
ClinPred
0.95
D
GERP RS
4.9
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.90
gMVP
0.92
Mutation Taster
=20/80
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs398123102; hg19: chrX-153005610; COSMIC: COSV106089412; API